Page last updated: 2024-08-26

s-nitrosoglutathione and Prostatic Neoplasms, Castration-Resistant

s-nitrosoglutathione has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arora, H; Dulce, RA; Firdaus, F; Hare, JM; Kuchakulla, M; Masterson, T; Punnen, S; Qureshi, R; Ramasamy, R; Rosete, OJ; Shah, K; Soni, Y; Van Booven, DJ	1

Other Studies

1 other study(ies) available for s-nitrosoglutathione and Prostatic Neoplasms, Castration-Resistant

Article	Year
S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer. Cell death & disease, 2022, 10-08, Volume: 13, Issue:10 Topics: Cysteine; Humans; Macrophage Colony-Stimulating Factor; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Prostatic Neoplasms, Castration-Resistant; Receptor, Macrophage Colony-Stimulating Factor; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; S-Nitrosoglutathione; Tumor Microenvironment	2022

Article

Year

S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer.

Cell death & disease, 2022, 10-08, Volume: 13, Issue:10

Topics: Cysteine; Humans; Macrophage Colony-Stimulating Factor; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Prostatic Neoplasms, Castration-Resistant; Receptor, Macrophage Colony-Stimulating Factor; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; S-Nitrosoglutathione; Tumor Microenvironment

2022